Blaess, M.; Kaiser, L.; Sommerfeld, O.; Csuk, R.; Deigner, H.-P.
Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19. Int. J. Mol. Sci. 2021, 22, 1797.
https://doi.org/10.3390/ijms22041797
AMA Style
Blaess M, Kaiser L, Sommerfeld O, Csuk R, Deigner H-P.
Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19. International Journal of Molecular Sciences. 2021; 22(4):1797.
https://doi.org/10.3390/ijms22041797
Chicago/Turabian Style
Blaess, Markus, Lars Kaiser, Oliver Sommerfeld, René Csuk, and Hans-Peter Deigner.
2021. "Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19" International Journal of Molecular Sciences 22, no. 4: 1797.
https://doi.org/10.3390/ijms22041797
APA Style
Blaess, M., Kaiser, L., Sommerfeld, O., Csuk, R., & Deigner, H.-P.
(2021). Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19. International Journal of Molecular Sciences, 22(4), 1797.
https://doi.org/10.3390/ijms22041797